Search Results

Patent life of antiretroviral drugs approved in the US from 1987 to 2007

Authors: Rodriguez-Monguio, Rosa; Seoane-Vazquez, Enrique

Source: AIDS Care, Volume 21, Number 6, June 2009 , pp. 760-768(9)

Publisher: Routledge, part of the Taylor & Francis Group

FDA drug approval intervals from 1997 to 2006: analysis and comparison during information technology implementation

Authors: Kros, John F.; Keller, Christopher M.

Source: International Journal of Electronic Healthcare, Volume 5, Number 2, 10 November 2009 , pp. 164-176(13)

Publisher: Inderscience Publishers

Change in formulation and its potential clinical and pharmacoeconomic value: example of extended release venlafaxine

Author: Haeusler, Jean-Marc C.

Source: Current Medical Research and Opinion, Volume 25, Number 5, May 2009 , pp. 1089-1094(6)

Publisher: Informa Healthcare

The prasugrel new drug application (NDA) is still under discussion with the US FDA

Source: Inpharma, Volume 1, Number 1661, 2008-10-25 , pp. 19-19(1)

Publisher: Adis International

A regulatory viewpoint on transporter-based drug interactions

Authors: Zhang, L.; Zhang, Y.; Strong, J. M.; Reynolds, K. S.; Huang, S. -M.

Source: Xenobiotica, Volume 38, Numbers 7-8, July 2008 , pp. 709-724(16)

Publisher: Informa Healthcare

Beclometasone Oral - DOR BioPharma: Beclomethasone Oral - DOR BioPharma

Author: Adis International Limited,

Source: Drugs in R&D, Volume 9, Number 4, 2008 , pp. 271-276(6)

Publisher: Adis International

Taro Pharmaceuticals U.S.A has received US FDA approval for its New Drug Application (NDA) for prednisolone acetate oral suspension [Flo-Pred].

Source: Inpharma, Volume 1, Number 1622, 2008-01-26 , pp. 22-22(1)

Publisher: Adis International

Clinical Trial Design: Integrating Biomarkers into Drug Development

Author: Aziz, Kaiser J.

Source: Journal of Clinical Ligand Assay, Volume 30, Numbers 1-2, Spring-Summer 2007 , pp. 10-19(10)

Publisher: Clinical Ligand Assay Society

Vernakalant: RSD 1235, RSD-1235, RSD1235

Author: Adis International Limited,

Source: Drugs in R&D, Volume 8, Number 4, 2007 , pp. 259-265(7)

Publisher: Adis International

Ruboxistaurin: LY 333531

Author: Adis International Limited,

Source: Drugs in R&D, Volume 8, Number 3, 2007 , pp. 193-199(7)

Publisher: Adis International

The Role of FDA in the Regulation of Anti-Cancer Drugs

Authors: Dagher, Ramzi N.; Pazdur, Richard

Source: Current Cancer Therapy Reviews, Volume 2, Number 4, November 2006 , pp. 327-329(3)

Publisher: Bentham Science Publishers

Gene Express Inc

Author: Saccomanno, Colette F

Source: Pharmacogenomics, Volume 7, Number 5, July 2006 , pp. 793-796(4)

Publisher: Future Medicine

Dapoxetine: LY 210448

Author: Adis International Limited,

Source: Drugs in R&D, Volume 6, Number 5, 2005 , pp. 307-311(5)

Publisher: Adis International

Application of Emerging Technologies in Toxicology and Safety Assessment: Regulatory Perspectives

Author: Leighton, John

Source: International Journal of Toxicology, Volume 24, Number 3, Number 3/May-June 2005 , pp. 153-155(3)

Publisher: Informa Healthcare

Lubiprostone: RU 0211, SPI 0211

Author: Adis International Limited,

Source: Drugs in R&D, Volume 6, Number 4, 2005 , pp. 245-248(4)

Publisher: Adis International

Cilansetron: KC 9946

Author: Adis International Limited,

Source: Drugs in R&D, Volume 6, Number 3, 2005 , pp. 169-173(5)

Publisher: Adis International

Emtricitabine/Tenofovir Disoproxil Fumarate

Author: Adis International Limited

Source: Drugs in R&D, Volume 5, Number 3, 2004 , pp. 160-161(2)

Publisher: Adis International

Arformoterol: (R,R)-Eformoterol, (R,R)-Formoterol, Arformoterol Tartrate, Eformoterol-Sepracor, Formoterol-Sepracor, R,R-Eformoterol, R,R-Formoterol

Author: Adis International Limited

Source: Drugs in R&D, Volume 5, Number 1, 2004 , pp. 25-27(3)

Publisher: Adis International

Detection of systemic hypersensitivity to drugs using standard guinea pig assays

Authors: Weaver J.L.; Staten D.; Swann J.; Armstrong G.; Bates M.; Hastings K.L.

Source: Toxicology, Volume 193, Number 3, 1 December 2003 , pp. 203-217(15)

Publisher: Elsevier

Oncology Drug Review Process

Authors: Farrell A.T.; Pazdur R.

Source: Journal of the National Comprehensive Cancer Network (JNCCN), Volume 1, Number 1, 1 March 2003 , pp. 109-113(5)

Publisher: Cold Spring Publishing, LLC